Neurana Pharmaceuticals Appoints Georgia Erbez and Liz Cermak to Board of Directors
Retrieved on:
Tuesday, June 1, 2021
SAN DIEGO, June 1, 2021 /PRNewswire/ --Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the appointment of Georgia Erbez and Elizabeth (Liz) Cermak to its Board of Directors.
Key Points:
- SAN DIEGO, June 1, 2021 /PRNewswire/ --Neurana Pharmaceuticals, a biotechnology company focused on the treatment of neuromuscular conditions, today announced the appointment of Georgia Erbez and Elizabeth (Liz) Cermak to its Board of Directors.
- Ms. Erbez and Ms. Cermak are accomplished, experienced life science executives and board directors.
- "We are very pleased to welcome Georgia and Liz as the newest members of our Board of Directors, both joining at a pivotal period of development for Neurana," said David F. Hale, Chairman of the Board.
- In addition, Ms. Cermak was formerly a board director at SteadyMed Therapeutics and served on the Board of a local non-profit, Ocean Ridge Charities Association, Inc..